Expert opinion: Can different assessments be used to overcome current candidacy issues?
Since the National Institute of Health and Care Excellence (NICE) review of cochlear implantation in 2009, (NICE, 2009) there have been a number of significant changes to our understanding of the impact of severe-to-profound hearing loss on quality of life and comorbidity with life limiting illness. There have been questions about the validity of current methods of assessing candidacy for cochlear implants. There have also been significant improvements in the effectiveness of implants, the age of successful implantation and a reduction in costs. Additionally, the costs to the health and welfare system of not addressing severe-to-profound hearing loss are often not considered when assessing costs and benefits of this technology and when assessing candidacy criteria. Consideration of these changes since the NICE review suggests the need for an urgent review of the current guidance.